PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.
$11.24
As of 05/20/2022 IEX book CBOE book
2022 © Stock Market MBA, Inc.